Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 100 | |||||
| (NASDAQ: IOVA) | Delayed: 4.04 -0.19 (4.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.23 | 52 Week High | $ | |||
| Open | $4.16 | 52 Week Low | $ | |||
| Day High | $4.17 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $ | |||
| Volume | 13,325,371 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 41.30 -1.25 (2.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.55 | 52 Week High | $4.38 | |||
| Open | $41.92 | 52 Week Low | $1.88 | |||
| Day High | $42.85 | P/E | N/A | |||
| Day Low | $40.77 | EPS | $-1.12 | |||
| Volume | 430,671 | |||||
